Our Work

The Opioid Policy Research Collaborative is a national resource for government agencies, health care systems, researchers and other stakeholders. OPRC offers rigorous scientific evaluation of interventions to reduce the incidence of opioid use disorder (OUD) and expand access to treatment for people suffering from this life-threatening condition. We also provide consulting services to aid in program development and implementation. For inquiries and requests, please contact us.

Intervention Design and Implementation

We invite policymakers who want to tackle the opioid addiction epidemic to call on us for guidance in designing and implementing public health and other policy interventions. The OPRC has deep expertise in working with public health officials, health care organizations and state/federal policymakers to construct effective interventions and legislation.

Policy Evaluation

OPRC researchers conduct rigorous evaluations of policies, programs and interventions designed to prevent and treat opioid addiction and substance use disorder. We regularly conduct outcome evaluations as well as process and implementation evaluations. Our researchers are experts in both qualitative and quantitative examination of such interventions.

Education and Training 

OPRC researchers regularly advise practitioners and policymakers, provide lectures and presentations, and convene stakeholders around best practices. This includes assisting state prescription drug monitoring program (PDMP) directors to identify risky prescribing patterns, guiding members of Congress (from both parties) on existing and proposed opioid policy legislation, and presenting new research and best practices at conferences and professional organizations.

Who We Serve

  • Federal, state and local government officials
    • Federal administrative agencies, such as SAMHSA, the CDC, and the FDA
    • Elected officials concerned with opioid-relevant legislation and their staff, including members of Congress, state governors, and attorneys general
    • Other public officials and policy makers, such as health commissioners, public health officials, state PDMP directors, and law enforcement agencies
  • Health care organizations, such as health insurance companies, managed care organizations, health systems and medical centers.*
  • Community-based organizations including nonprofits and advocacy groups.

*The OPRC receives no funding from pharmaceutical companies.